Drug and Therapeutics Bulletin 2003;41:1-4; doi:10.1136/dtb.2003.4111
Copyright © 2003 by the BMJ Publishing Group Ltd.
Drugs for disruptive features in dementia
It is estimated that around 750,000 people in the UK have dementia and, of these, 60% will have behavioural changes or psychological symptoms.1–3 These features tend to occur in clusters, of which the five most readily recognised are characterised by aggression, apathy, depression, psychomotor agitation or psychosis.4 Here, we review the place of drug therapy in the management of patients in whom these features are disruptive.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
(2007). How safe are antipsychotics in dementia?. DTB
45: 81-85
[Abstract] [Full Text] -
Alldred, D. P., Petty, D. R., Bowie, P., Zermansky, A. G., Raynor, D. K.
(2007). Antipsychotic prescribing patterns in care homes and relationship with dementia. Psychiatr. Bull.
31: 329-332
[Abstract] [Full Text] -
Flohr, C., Williams, H. C
(2004). Evidence based management of atopic eczema. EDUCATION AND PRACTICE
89: ep35-ep39
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
